Free Trial

KP Tissue (TSE:KPT) Sets New 52-Week High - What's Next?

KP Tissue logo with Consumer Defensive background

KP Tissue Inc. (TSE:KPT - Get Free Report)'s stock price hit a new 52-week high during trading on Monday . The stock traded as high as C$9.23 and last traded at C$9.25, with a volume of 20645 shares changing hands. The stock had previously closed at C$9.17.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on KPT. Desjardins upped their price target on shares of KP Tissue from C$8.50 to C$9.50 and gave the stock a "hold" rating in a report on Thursday, May 22nd. TD Securities upped their target price on KP Tissue from C$8.00 to C$9.00 and gave the stock a "hold" rating in a research note on Thursday, May 22nd. Finally, National Bankshares raised their target price on KP Tissue from C$8.50 to C$9.50 and gave the company a "sector perform" rating in a report on Thursday, May 22nd.

Check Out Our Latest Report on KP Tissue

KP Tissue Stock Performance

The firm has a market cap of C$92.35 million, a price-to-earnings ratio of 14.47, a PEG ratio of -0.88 and a beta of 0.37. The business has a fifty day simple moving average of C$8.46 and a 200-day simple moving average of C$8.20.

About KP Tissue

(Get Free Report)

KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in KP Tissue Right Now?

Before you consider KP Tissue, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.

While KP Tissue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now
Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines